Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections — REACH  

Community Acquired Pneumonia (CAP) Clinical Trial

Official title: Observational Study to Assess Clinical Management Patterns in Patients With Hospitalised Community-Acquired Pneumonia (CAP) or Complicated Skin and Skin Structure Infections (cSSSI)

Status Completed

Clinical Trial Summary

This study will collect real-life data from patients with community acquired pneumonia (CAP) OR complicated skin and skin structure infections (cSSSI) to assess the burden of the disease, review the treatment pathways, evaluate how health resources are used and identify any areas of unmet medical needs. The aim of the study is to compare how patients who are admitted to hospital with CAP or cSSSI are managed across Europe. This will be done by collecting data to understand the patient and disease characteristics, current practice of treatment, and outcomes for the patient. Overall 4000 patients will be recruited from 10 European countries.

Clinical Trial Description

n/a

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Communicable Diseases
• Community Acquired Pneumonia (CAP)
• Complicated Skin and Skin Structures Infections (cSSSI)
• Infection
• Pneumonia

• NCT number: NCT01293435
• Study type: Observational
• Source: AstraZeneca
• Status: Completed
• Phase: N/A
• Start date: March 2011
• Completion date: June 2011